Benzbromarone biotransformation is not related to polymorphic oxidation of sparteine

This publication has 9 references indexed in Scilit:

• Characterization of the common genetic defect in humans deficient in debrisoquine metabolism
  Nature, 1988
• Benzbromarone disposition and uricosuric action; evidence for hydroxilation instead of debromination to benzarone
  Klinische Wochenschrift, 1988
• Analysis of benzbromarone in human plasma and urine by high-performance liquid chromatography and gas chromatography—mass spectrometry
  Journal of Chromatography B: Biomedical Sciences and Applications, 1987
• Genetically Determined Variability in Acetylation and Oxidation Therapeutic Implications
  Drugs, 1985
• [Genetic polymorphism of oxidative drug metabolism. Therapeutic and toxicologic implications].
  1983
• Antipyrine metabolism in relation to polymorphic oxidations of sparteine and debrisoquine.
  British Journal of Clinical Pharmacology, 1983
• Polymorphic oxidation of sparteine and debrisoquine: Related pharmacogenetic entities
  Clinical Pharmacology & Therapeutics, 1982
• Defective Oxidation of Drugs
  Clinical Pharmacokinetics, 1982
• Defective N-oxidation of sparteine in man: A new pharmacogenetic defect
  European Journal of Clinical Pharmacology, 1979